DIRECTING THE STATE EMPLOYEE BENEFITS COMMITTEE AND THE SECRETARY OF HUMAN RESOURCES TO ENGAGE WITH INDEPENDENT CONSULTANTS AND OTHER SUPPLY CHAIN TACTICS FOR COST CONTAINMENT OF PRESCRIPTION DRUGS FOR STATE EMPLOYEES AND RETIREES’ INSURANCE PROGRAMS.
Sponsored By: Ray Seigfried (Democratic)
Signed by Governor
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Lower drug costs for state workers
The State creates an independent Pharmacy and Therapeutics Committee for state employee and retiree plans and hires a consultant paid to find the lowest-cost drugs and favor generics when brands add no benefit. The SEBC uses tactics like reverse auctions and will own a drug-price database. The State must own real-time point‑of‑sale price data. PBMs must bid using the lowest price source, not AWP, and must disclose all administrative costs. SEBC can see PBM–manufacturer deals, and it has audit rights with an outside auditor. By December 1, 2025, SEBC must report any barriers to carrying out these policies.
Medicare price cap for state plans
The State cannot pay more than Medicare’s negotiated price for any drug that Medicare has negotiated. This applies when buying drugs for state employee and retiree health plans. The cap limits what the State pays and aims to hold down plan costs.
Multi-state drug buying for Delawareans
Delaware joins with other states to negotiate directly with drug makers for high-priced drugs. The State uses combined buying power to seek lower prices. After talks finish, the State offers a consumer option based on those deals to all Delaware residents.
Sponsors & Cosponsors
Sponsor
Ray Seigfried
Democratic • Senate
Cosponsors
Eric Buckson
Republican • Senate
Stephanie L. Hansen
Democratic • Senate
Jeff Hilovsky
Republican • House
Melissa Minor-Brown
Democratic • House
Edward S. Osienski
Democratic • House
Marie Pinkney
Democratic • Senate
David P. Sokola
Democratic • Senate
Bryan Townsend
Democratic • Senate
John "Jack" Walsh
Democratic • Senate
David L. Wilson
Republican • Senate
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
SS 1 for SJR 7 - Signed by Governor
8/25/2025GovernorSS 1 for SJR 7 - Passed By Senate. Votes: 21 YES
7/1/2025SenateSS 1 for SJR 7 - Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT
6/30/2025HouseSS 1 for SJR 7 - - Passed In House by Voice Vote
6/30/2025HouseSS 1 for SJR 7 - Reported Out of Committee (Administration) in House with 5 On Its Merits
6/25/2025HouseSS 1 for SJR 7 - Assigned to Administration Committee in House
5/22/2025HouseSS 1 for SJR 7 - Passed By Senate. Votes: 19 YES 2 ABSENT
5/21/2025SenateSubstituted in Senate by SS 1 for SJR 7
5/21/2025SenateReported Out of Committee (Health & Social Services) in Senate with 6 Favorable, 2 On Its Merits
5/14/2025SenateIntroduced and Assigned to Health & Social Services Committee in Senate
5/9/2025Senate
Bill Text
Current
5/9/2025
Related Bills
SB 110 — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO THE EXAMINING BOARD OF PHYSICAL THERAPISTS AND ATHLETIC TRAINERS.
HB 221 — AN ACT TO AMEND TITLE 3 OF THE DELAWARE CODE RELATING TO PESTICIDES.
HB 191 — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO MEDICAL PROFESSIONALS, TITLES, AND NONHUMAN ENTITIES.
HB 266 w/ SA 1 — AN ACT TO AMEND TITLE 21 OF THE DELAWARE CODE RELATING TO MOTORIZED SCOOTERS.
HB 231 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO UNIFORM HEALTH DATA.
SB 191 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE DELAWARE INSTITUTE FOR DENTAL EDUCATION AND RESEARCH.